These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25754418)

  • 1. Tolerance of platelet concentrates treated with UVC-light only for pathogen reduction--a phase I clinical trial.
    Thiele T; Pohler P; Kohlmann T; Sümnig A; Aurich K; Selleng K; Westphal A; Bakchoul T; Petersmann A; Müller TH; Greinacher A; Seltsam A
    Vox Sang; 2015 Jul; 109(1):44-51. PubMed ID: 25754418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the tolerability and immunogenicity of ultraviolet C-irradiated autologous platelets in a dog model.
    Pohler P; Lehmann J; Veneruso V; Tomm J; von Bergen M; Lambrecht B; Kohn B; Weingart C; Müller TH; Seltsam A
    Transfusion; 2012 Nov; 52(11):2414-26. PubMed ID: 22404822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of the THERAFLEX UV-Platelets pathogen inactivation system - an update.
    Seghatchian J; Tolksdorf F
    Transfus Apher Sci; 2012 Apr; 46(2):221-9. PubMed ID: 22365926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of increased agitation speed on pathogen inactivation efficacy and in vitro quality in UVC-treated platelet concentrates.
    van der Meer PF; Gravemann U; de Korte D; Sumian C; Tolksdorf F; Müller TH; Seltsam A
    Vox Sang; 2016 Aug; 111(2):127-34. PubMed ID: 27167507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogen reduction by ultraviolet C light effectively inactivates human white blood cells in platelet products.
    Pohler P; Müller M; Winkler C; Schaudien D; Sewald K; Müller TH; Seltsam A
    Transfusion; 2015 Feb; 55(2):337-47. PubMed ID: 25134439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characteristics and clinical effectiveness of platelet concentrates treated with riboflavin and ultraviolet light in plasma and in platelet additive solution.
    Ignatova AA; Karpova OV; Trakhtman PE; Rumiantsev SA; Panteleev MA
    Vox Sang; 2016 Apr; 110(3):244-52. PubMed ID: 26646605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of platelet concentrates with ultraviolet C light for pathogen reduction increases cytokine accumulation.
    Sandgren P; Berlin G; Tynngård N
    Transfusion; 2016 Jun; 56(6):1377-83. PubMed ID: 27080102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogen inactivation of platelets using ultraviolet C light: effect on in vitro function and recovery and survival of platelets.
    Bashir S; Cookson P; Wiltshire M; Hawkins L; Sonoda L; Thomas S; Seltsam A; Tolksdorf F; Williamson LM; Cardigan R
    Transfusion; 2013 May; 53(5):990-1000. PubMed ID: 22905813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial DNA multiplex real-time polymerase chain reaction inhibition assay for quality control of pathogen inactivation by ultraviolet C light in platelet concentrates.
    Kim S; Handke W; Gravemann U; Döscher A; Brixner V; Müller TH; Seltsam A
    Transfusion; 2018 Mar; 58(3):758-765. PubMed ID: 29282743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effects on platelets irradiated with short-wave ultraviolet light without any additional photoactive reagent using the THERAFLEX UV-Platelets method.
    Sandgren P; Tolksdorf F; Struff WG; Gulliksson H
    Vox Sang; 2011 Jul; 101(1):35-43. PubMed ID: 21175668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro function of platelets treated with ultraviolet C light for pathogen inactivation: a comparative study with nonirradiated and gamma-irradiated platelets.
    Tynngård N; Trinks M; Berlin G
    Transfusion; 2015 Jun; 55(6):1169-77. PubMed ID: 25524519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo characterization of ultraviolet light C-irradiated human platelets in a 2 event mouse model of transfusion.
    Zhi L; Chi X; Vostal JG
    PLoS One; 2013; 8(11):e79869. PubMed ID: 24224014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial inactivation of platelet concentrates with the THERAFLEX UV-Platelets pathogen inactivation system.
    Gravemann U; Handke W; Müller TH; Seltsam A
    Transfusion; 2019 Apr; 59(4):1324-1332. PubMed ID: 30588633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis E virus is effectively inactivated in platelet concentrates by ultraviolet C light.
    Praditya D; Friesland M; Gravemann U; Handke W; Todt D; Behrendt P; Müller TH; Steinmann E; Seltsam A
    Vox Sang; 2020 Oct; 115(7):555-561. PubMed ID: 32383163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products.
    Steinmann E; Gravemann U; Friesland M; Doerrbecker J; Müller TH; Pietschmann T; Seltsam A
    Transfusion; 2013 May; 53(5):1010-8. PubMed ID: 22905868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light.
    Mohr H; Steil L; Gravemann U; Thiele T; Hammer E; Greinacher A; Müller TH; Völker U
    Transfusion; 2009 Dec; 49(12):2612-24. PubMed ID: 19682340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light.
    Fryk JJ; Marks DC; Hobson-Peters J; Watterson D; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Faddy HM
    Transfusion; 2017 Nov; 57(11):2677-2682. PubMed ID: 28718518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of transfusion efficacy of amotosalen-based pathogen-reduced platelet components and gamma-irradiated platelet components.
    Sigle JP; Infanti L; Studt JD; Martinez M; Stern M; Gratwohl A; Passweg J; Tichelli A; Buser AS
    Transfusion; 2013 Aug; 53(8):1788-97. PubMed ID: 23176347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of amotosalen-ultraviolet A pathogen-inactivated platelets stored for up to 7 days.
    Infanti L; Holbro A; Passweg J; Bolliger D; Tsakiris DA; Merki R; Plattner A; Tappe D; Irsch J; Lin JS; Corash L; Benjamin RJ; Buser A
    Transfusion; 2019 Nov; 59(11):3350-3361. PubMed ID: 31574181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.